Exclusive Interview with Ken Fisher about the Stock Market Under Trump versus Biden

 Please note that this is a sister publication of WallStreetNewsNetwork ( https://WStNN.com ) and postings will end on this site shortly.  

 by Fred Fuld III

The following informative interview was provided by Kenneth L. Fisher, founder and chairman of the money management firm Fisher Investments, who had the longest continuous running column in Forbes Magazine. He is a billionaire on the Forbes 400 list and author of numerous investment related books.

According to Investment Advisor magazine, he is one of the 30 most influential people in the investment advisory business over the last 30 years. Fisher is considered to be the largest wealth manager in the United States.

We cover a lot in this interview, including:

• The stock market under President Donald Trump versus former Vice President Joe Biden
• The influence of corporate tax rate on the stocks 
• The potential of the reversal of Trump’s tax bill on Day One if Joe Biden & Kamila Harris win the election
• The market under Republicans versus Democrats
• Whether inflation is on the horizon
• The petroleum industry
• Gross Output, GDP, and the economy versus the stock market
• Are stock ratios dead? (PE, PS, PEG)
• And much, much more

Two Timeless Books Mentioned by Ken Fisher in the Interview

The Only Three Questions That Still Count: Investing By Knowing What Others Don’t (A great companion to the  Beat the Crowd: How You Can Out-Invest the Herd by Thinking Differently book, which I enjoyed reading.)

Wall Street Waltz 

(My favorite of all his books is The Ten Roads to Riches: The Ways the Wealthy Got There (And How You Can Too!) Second Edition,  because it is so different from all the other financial publications. It basically tells you ten ways, with all the steps, to get really rich, including “marrying a billionaire.” Lot’s of insight and lots of humor. You can find more info about this book on a previous podcast: Interview with Billionaire Ken Fisher about the 10 Roads to Riches.)

The Interview

Enjoy listening to the great insights and  information that Ken Fisher provides.

To access a link to the interview, click:

HERE

Enjoy the interview and Happy Investing!

All opinions are those of Ken Fisher, and do not represent the opinions of this site or the interviewer. Neither this site, nor the interviewer, nor the interviewee are rendering tax, legal, or investment advice in this interview. As an Amazon Associate, earnings may be generated from qualifying purchases of books from affiliate links.

Top Sports Betting Stocks

 Please note that this is a sister publication of WallStreetNewsNetwork ( https://WStNN.com ) and postings will end on this site shortly. 

Sports are coming back. Online betting is increasing. What companies are benefiting?

Two years ago, the Supreme Court allowed betting on sports in all states, with each state deciding whether to allow this form of gambling or not. Several states have already legalized online sports betting. Many more states are considering legislation. These changes should lead to more online gambling, and a transition from illegal gambling to legal betting.

Even NBC Sports Broadcaster Jim Kozimor mentioned in an interview that sports betting will be an extremely strong growth industry.

So if you are looking for a way to profit from sports gambling, you should look at the stocks that should benefit from the online betting on sports events.

DraftKings (DKNG) is one of the largest pure plays in the online sports betting arena. This was one of the stocks that was created from a SPAC. Revenues for this $20.6 billion market cap company were up 23.6% for the latest quarter. Earnings are minimal giving it a price to earnings ratio of over 1000.

Flutter Entertainment (PDYPY) is one of the largest daily fantasy sports providers and a leader in the legal sports betting market. The company was formerly named Paddy Power Betfair. This $25 billion market cap company trades at 47.5 times earnings.

Boyd Gaming Corp. (BYD), an operator of a company that runs over a dozen casinos across the United States, offers its B Connected Sports app in order to take advantage of increased legalization. The stock trades at 30.9 times forward earnings.

to see a list of over 20 companies that may benefit from online sports betting and Internet gambling, sorted in order of market cap, click HERE.Maybe some of these stocks will win big.

Disclosure: Author owns DKNG

Stocks Going Ex Dividend in October 2020

Please note that this is a sister publication of WallStreetNewsNetwork ( https://WStNN.com ) and postings will end on this site shortly. 

The following is a short list of some of the many stocks going ex dividend during the next month.

Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the strategy of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend.

TOP DIVIDEND STOCKS

This technique generally works in bull markets and flat or choppy markets, but you need to avoid the strategy during bear markets. In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can’t sell the stock until after the ex date.

The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable and sortable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million, and many with yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, the periodic dividend amount.

Keurig Dr Pepper Inc. (KDP)	10/1/2020	0.15	2.21%
Oracle Corporation (ORCL)	10/7/2020	0.24	1.61%
Foot Locker, Inc. (FL)	10/15/2020	0.15	1.87%
Lowe’s Companies, Inc. (LOW)	10/20/2020	0.60	1.48%
Williams-Sonoma, Inc. (WSM)	10/22/2020	0.48	2.15%
Royal Bank Of Canada (RY)	10/23/2020	0.828	4.68%

The additional ex-dividend stocks can be found HERE . (If you have been to the page before, and the latest link doesn’t show up, you may have to empty your cache.) If you like dividend stocks, you should check out some of the other high yield stock lists HERE . Most of the lists are free.

Dividend definitions:

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Record date: the day when you must be on the company’s books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

TOP DIVIDEND STOCKS

Don’t forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written; affiliate links.

Try the Warren Buffett-style Stock Analyzer for FREE!

Top Dividend Stocks
Top 100 Dividend Stocks, Ex-dividend Ratings, High Yield Ratings, Monthly Reports And More

Over a Dozen Psychedelic Stocks to Choose From

Please note that this is a sister publication of Wall Street News Network ( https://WStNN.com ) and postings will end on this site shortly.  

 by Fred Fuld III

It was one year ago at the San Francisco MoneyShow that I gave a speech called Stocks of Leading Future Industries. In that presentation on August 16, 2019, I covered seven leading industries, plus one bonus industry.

The bonus industry was Legalized Hallucinogenic Drugs, primarily the legalization of psilocybin and the industry around its use for therapeutic purposes.

First Public Psilocybin Stock

At that time, there was only one publicly traded stock involved in researching psilocybin, Wuhan General (WUHN), which had a division, M2BIO, that was exploring the medical use of psilocybin for treatments of various conditions.

I didn't recommend the stock during the speech, (I never make any recommendations, I only come up with suggestions for you to research), but I did say that one of these days, this stock will start to move up, other psilocybin companies will go public, and these stocks could take off just like the cannabis stocks did in the past. I told the audience to watch this stock and the industry. You can see my speech below. The section on the psilocybin and psychedelic pharmaceutical industry is at the 25 minute mark.

 

If you want to see a pdf of the slides from the presentation, you can go HERE.

The Alert About Psychedelic Stocks

So why was it important to keep an eye on this stock? From November 20, 2019 to May 20, 2020, the stock traded between 2 cents a share to 4 cents a share. The next day, the stock almost doubled to 7 cents a share. It then traded at 8 cents a share for a couple days, and jumped by 50% to 12 cents a share the next day. After that, it really started to move.

So there were exactly six months that you could have picked up the stock for, let's say, 3 cents a share, halfway between the trading range. The stock closed at 33 cents on Friday (actually 32.75 cents but I rounded to make the calculation easier).

This works out to a 1,000% profit on Wuhan. In other words, if you had invested $5,000 at 3 cents per share, the shareholdings would now be worth $50,000. Actually the stock has even traded above 42 cents since May.

The movement of the shares should have been an alert to investors and traders.

Why the Potential for the Psychedelic Drug Industry

In my presentation, I discussed how extensive research is being done with health treatment studies on the use of psilocybin to treat:

•Anxiety disorders

•Major depression

•Addictions

•Drug dependence

•Mood disorders

•Treatment Resistant Depression

•OCD

•PTSD

 

I also mentioned that psilocybin and magic mushrooms have been decriminalized or legalized in:

 

–Denver, Colorado (May 2019)

–Oakland, California (June 2019)

–Austria (possession decriminalized 2016)

–Brazil

–Iceland (fresh mushrooms only)

–Jamaica

–Netherlands (legal as truffle)

–Portugal (decriminalized)

–Samoa

–Spain (decriminalized for personal use)

–Vietnam

 

Since then, Santa Cruz has decriminalized psilocybin in January of this year.

Is There a Precedent for Using Hallucinogenic Drugs Medically?

There have actually been examples of hallucinogenic drugs being used for medical purposes. One example is Lorcaserin [BELVIQ], which is a hallucinogen, but has been marketed for weight loss in very low doses. The Schedule I hallucinogen psilocybin has the same mechanism of action as Lorcaserin, according to the U. S. Government National Institute of Health. Arena (ARNA) markets the drug in the U.S. and South Korea, and Eisai Co Ltd (ESALY) manufactures and distributes the drug.

 

Another example is Spravato, which is a derivative of the psychedelic ketamine, and is being used for depression. It is produced by Johnson & Johnson (JNJ).

 

What's Happening Now with Psychedelic Drugs and Stocks

On Friday, September 18, 2020, Compass Pathways (CMPS) went public, trading on the NASDAQ. The company's IPO was priced at $17 per share, up from a range of $14 to $16, due to the huge demand.

 

Once it started trading it skyrocketed to $29 a share, an increase of over 70%, and putting the market cap at almost a billion dollars.

 

The company, which is based in England, is doing therapeutic research on the use of psilocybin for depression.

 

There are now over a dozen stocks involved in the psilocybin and psychedelic drug industry. To see a list of these stocks, click HERE.

 

Maybe some of these stocks will get higher and higher.

 

Disclosure: Author owns a very small amount of CMPS (less than 10 shares) at the time the article was written.